• 1
    Spee B, Arends B, Van Den Ingh TS, et al. Copper metabolism and oxidative stress in chronic inflammatory and cholestatic liver diseases in dogs. J Vet Intern Med 2006;20:10851092.
  • 2
    Forman OP, Boursnell MEG, Dunmore BJ, et al. Characterization of the COMMD1 (MURR1) mutation causing copper toxicosis in Bedlington terriers. Animal Genetics 2005;36:497501.
  • 3
    Chu L, Ravanshad W, Owen CA, et al. A comparison of copper-loading disease in Bedlington terriers and Wilson's disease in humans. Am J Physio 1982;243:G226G230.
  • 4
    Thornburg LP, Rottinghaus G, McGowan M. Hepatic copper concentrations in purebred and mixed-breed dogs. Vet Pathol 1990;27:8188.
  • 5
    Thornburg LP, Rottinghaus G, Dennis G, Crawford S. The relationship between hepatic copper content and morphologic changes in the liver of West Highland white terriers. Vet Pathol 1996;33:656661.
  • 6
    Van Den Ing TSGAM, Winkle TV, Cullen JM, et al. Morphologic classification of parenchymal disorders of the canine and feline liver. In: RothuizenJ, BunchSE, CharlesJA, et al, eds. WSAVA Standards for Clinical and Histological Diagnosis of Canine and Feline Liver Disease. Philadelphia, PA: Saunders Elsevier; 2006:9596.
  • 7
    Webb C, Twedt D, Meyer D. Copper-associated liver disease in Dalmatians: A review of 10 dogs (1998–2001). J Vet Intern Med 2002;16:665668.
  • 8
    Noaker L, Washabau R, Detrisac C, et al. Copper associated acute hepatic failure in a dog. J Am Vet Med Assoc 1999;214:15021506.
  • 9
    Das SK, Ray K. Wilson's disease: An update. Nature Clin Pract Neur 2006;2:482493.
  • 10
    El-Youssef M. Wilson disease. Mayo Clin Proc 2003;78:11261136.
  • 11
    Elsas L, Hayslett J, Spargo B, et al. Wilson's disease with reversible renal tubular dysfunction: Correlation with proximal tubular ultrastructure. Ann Intern Med 1971;75:427433.
  • 12
    Bearn AG, Yu TF, Gutman AB. Renal function in Wilson's disease. J Clin Invest 1957;36(7):11071114.
  • 13
    Schonheyder F, Gregersen G, Hansen HE, Skov PE. Renal clearances of different amino acids in Wilson's disease before and after treatment with penicillamine. Acta Med Scand 1971;190:395399.
  • 14
    Walshe JM. Effect of penicillamine on failure of renal acidification in Wilson's disease. Lancet 1968;1(7546):775778.
  • 15
    Troelstra JA, Holl H. Penicillamine for tubular dysfunction in Wilson's disease. In letters to the editor. Lancet May 1968;1094.
  • 16
    Sozeri E, Feist D, Ruder H, Scharer K. Proteinuria and other renal functions in Wilson's disease. Pediatr Nephrol 1997;11:307311.
  • 17
    Haywood S. Copper toxicosis and tolerance in the rat. I—Changes in the copper content of the liver and kidney. J Pathol 1985;145:149158.
  • 18
    Fuentealba IC, Haywood S, Foster J. Cellular mechanisms of toxicity and tolerance in the copper-loaded rat. III Ultrastructural changes and copper localization in the kidney. Br J Exp Path 1989;70:543556.
  • 19
    Krstic D, Krinulovic K, Vasic V. Inhibition of Na+/K+-ATPase and Mg2+-ATPase by metal ions and prevention and recovery of inhibited activities by chelators. J Enz Inhib Med Chem 2005;20:469476.
  • 20
    Kramer H, Gonick H, Lu E. In vitro inhibition of Na-K-ATPase by trace metals: Relation to renal and cardiovascular damage. Nephron 1986;44:329336.